IBDEI0QH ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11912,1,2,0)
;;=2^J3380
;;^UTILITY(U,$J,358.3,11912,1,3,0)
;;=3^VEDOLIZUMAB/ENTYVIO 1MG
;;^UTILITY(U,$J,358.3,11913,0)
;;=J7609^^48^580^5^^^^1
;;^UTILITY(U,$J,358.3,11913,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11913,1,2,0)
;;=2^J7609
;;^UTILITY(U,$J,358.3,11913,1,3,0)
;;=3^ALBUTEROL,COMPOUND,UNIT DOSE,1MG
;;^UTILITY(U,$J,358.3,11914,0)
;;=J7610^^48^580^4^^^^1
;;^UTILITY(U,$J,358.3,11914,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11914,1,2,0)
;;=2^J7610
;;^UTILITY(U,$J,358.3,11914,1,3,0)
;;=3^ALBUTEROL,COMPOUND,CONCENTRATE,1MG
;;^UTILITY(U,$J,358.3,11915,0)
;;=J0735^^48^580^27^^^^1
;;^UTILITY(U,$J,358.3,11915,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11915,1,2,0)
;;=2^J0735
;;^UTILITY(U,$J,358.3,11915,1,3,0)
;;=3^CLONIDINE HYDROCHLORIDE 1MG
;;^UTILITY(U,$J,358.3,11916,0)
;;=J1438^^48^580^35^^^^1
;;^UTILITY(U,$J,358.3,11916,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11916,1,2,0)
;;=2^J1438
;;^UTILITY(U,$J,358.3,11916,1,3,0)
;;=3^ETANERCEPT 25MG
;;^UTILITY(U,$J,358.3,11917,0)
;;=J7611^^48^580^6^^^^1
;;^UTILITY(U,$J,358.3,11917,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11917,1,2,0)
;;=2^J7611
;;^UTILITY(U,$J,358.3,11917,1,3,0)
;;=3^ALBUTEROL,NON-COMPOUND,CONCENTRATE,1MG
;;^UTILITY(U,$J,358.3,11918,0)
;;=J7613^^48^580^7^^^^1
;;^UTILITY(U,$J,358.3,11918,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11918,1,2,0)
;;=2^J7613
;;^UTILITY(U,$J,358.3,11918,1,3,0)
;;=3^ALBUTEROL,NON-COMPOUND,UNIT DOSE,1MG
;;^UTILITY(U,$J,358.3,11919,0)
;;=J2680^^48^580^41^^^^1
;;^UTILITY(U,$J,358.3,11919,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11919,1,2,0)
;;=2^J2680
;;^UTILITY(U,$J,358.3,11919,1,3,0)
;;=3^FLUPHENAZINE DECANOATE,UP TO 25MG
;;^UTILITY(U,$J,358.3,11920,0)
;;=J1580^^48^580^47^^^^1
;;^UTILITY(U,$J,358.3,11920,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11920,1,2,0)
;;=2^J1580
;;^UTILITY(U,$J,358.3,11920,1,3,0)
;;=3^GARAMYCIN,GENTAMICIN,UP TO 80MG
;;^UTILITY(U,$J,358.3,11921,0)
;;=J2350^^48^580^80^^^^1
;;^UTILITY(U,$J,358.3,11921,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11921,1,2,0)
;;=2^J2350
;;^UTILITY(U,$J,358.3,11921,1,3,0)
;;=3^OCRELIZUMAB 1MG
;;^UTILITY(U,$J,358.3,11922,0)
;;=J3590^^48^580^105^^^^1
;;^UTILITY(U,$J,358.3,11922,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11922,1,2,0)
;;=2^J3590
;;^UTILITY(U,$J,358.3,11922,1,3,0)
;;=3^UNCLASSIFIED BIOLOGICS
;;^UTILITY(U,$J,358.3,11923,0)
;;=J3490^^48^580^106^^^^1
;;^UTILITY(U,$J,358.3,11923,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11923,1,2,0)
;;=2^J3490
;;^UTILITY(U,$J,358.3,11923,1,3,0)
;;=3^UNCLASSIFIED DRUG
;;^UTILITY(U,$J,358.3,11924,0)
;;=J0135^^48^580^3^^^^1
;;^UTILITY(U,$J,358.3,11924,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11924,1,2,0)
;;=2^J0135
;;^UTILITY(U,$J,358.3,11924,1,3,0)
;;=3^ADALIMUMAB 20MG
;;^UTILITY(U,$J,358.3,11925,0)
;;=J1569^^48^580^45^^^^1
;;^UTILITY(U,$J,358.3,11925,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11925,1,2,0)
;;=2^J1569
;;^UTILITY(U,$J,358.3,11925,1,3,0)
;;=3^GAMMAGARD LIQUID 500MG
;;^UTILITY(U,$J,358.3,11926,0)
;;=J1566^^48^580^51^^^^1
;;^UTILITY(U,$J,358.3,11926,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11926,1,2,0)
;;=2^J1566
;;^UTILITY(U,$J,358.3,11926,1,3,0)
;;=3^IMMUNE GLOBULIN 500MG
;;^UTILITY(U,$J,358.3,11927,0)
;;=J2182^^48^580^69^^^^1
;;^UTILITY(U,$J,358.3,11927,1,0)
;;=^358.31IA^3^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0QH 3769 printed Apr 09, 2024@21:52:55 Page 2
IBDEI0QH ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11912,1,2,0)
+2 ;;=2^J3380
+3 ;;^UTILITY(U,$J,358.3,11912,1,3,0)
+4 ;;=3^VEDOLIZUMAB/ENTYVIO 1MG
+5 ;;^UTILITY(U,$J,358.3,11913,0)
+6 ;;=J7609^^48^580^5^^^^1
+7 ;;^UTILITY(U,$J,358.3,11913,1,0)
+8 ;;=^358.31IA^3^2
+9 ;;^UTILITY(U,$J,358.3,11913,1,2,0)
+10 ;;=2^J7609
+11 ;;^UTILITY(U,$J,358.3,11913,1,3,0)
+12 ;;=3^ALBUTEROL,COMPOUND,UNIT DOSE,1MG
+13 ;;^UTILITY(U,$J,358.3,11914,0)
+14 ;;=J7610^^48^580^4^^^^1
+15 ;;^UTILITY(U,$J,358.3,11914,1,0)
+16 ;;=^358.31IA^3^2
+17 ;;^UTILITY(U,$J,358.3,11914,1,2,0)
+18 ;;=2^J7610
+19 ;;^UTILITY(U,$J,358.3,11914,1,3,0)
+20 ;;=3^ALBUTEROL,COMPOUND,CONCENTRATE,1MG
+21 ;;^UTILITY(U,$J,358.3,11915,0)
+22 ;;=J0735^^48^580^27^^^^1
+23 ;;^UTILITY(U,$J,358.3,11915,1,0)
+24 ;;=^358.31IA^3^2
+25 ;;^UTILITY(U,$J,358.3,11915,1,2,0)
+26 ;;=2^J0735
+27 ;;^UTILITY(U,$J,358.3,11915,1,3,0)
+28 ;;=3^CLONIDINE HYDROCHLORIDE 1MG
+29 ;;^UTILITY(U,$J,358.3,11916,0)
+30 ;;=J1438^^48^580^35^^^^1
+31 ;;^UTILITY(U,$J,358.3,11916,1,0)
+32 ;;=^358.31IA^3^2
+33 ;;^UTILITY(U,$J,358.3,11916,1,2,0)
+34 ;;=2^J1438
+35 ;;^UTILITY(U,$J,358.3,11916,1,3,0)
+36 ;;=3^ETANERCEPT 25MG
+37 ;;^UTILITY(U,$J,358.3,11917,0)
+38 ;;=J7611^^48^580^6^^^^1
+39 ;;^UTILITY(U,$J,358.3,11917,1,0)
+40 ;;=^358.31IA^3^2
+41 ;;^UTILITY(U,$J,358.3,11917,1,2,0)
+42 ;;=2^J7611
+43 ;;^UTILITY(U,$J,358.3,11917,1,3,0)
+44 ;;=3^ALBUTEROL,NON-COMPOUND,CONCENTRATE,1MG
+45 ;;^UTILITY(U,$J,358.3,11918,0)
+46 ;;=J7613^^48^580^7^^^^1
+47 ;;^UTILITY(U,$J,358.3,11918,1,0)
+48 ;;=^358.31IA^3^2
+49 ;;^UTILITY(U,$J,358.3,11918,1,2,0)
+50 ;;=2^J7613
+51 ;;^UTILITY(U,$J,358.3,11918,1,3,0)
+52 ;;=3^ALBUTEROL,NON-COMPOUND,UNIT DOSE,1MG
+53 ;;^UTILITY(U,$J,358.3,11919,0)
+54 ;;=J2680^^48^580^41^^^^1
+55 ;;^UTILITY(U,$J,358.3,11919,1,0)
+56 ;;=^358.31IA^3^2
+57 ;;^UTILITY(U,$J,358.3,11919,1,2,0)
+58 ;;=2^J2680
+59 ;;^UTILITY(U,$J,358.3,11919,1,3,0)
+60 ;;=3^FLUPHENAZINE DECANOATE,UP TO 25MG
+61 ;;^UTILITY(U,$J,358.3,11920,0)
+62 ;;=J1580^^48^580^47^^^^1
+63 ;;^UTILITY(U,$J,358.3,11920,1,0)
+64 ;;=^358.31IA^3^2
+65 ;;^UTILITY(U,$J,358.3,11920,1,2,0)
+66 ;;=2^J1580
+67 ;;^UTILITY(U,$J,358.3,11920,1,3,0)
+68 ;;=3^GARAMYCIN,GENTAMICIN,UP TO 80MG
+69 ;;^UTILITY(U,$J,358.3,11921,0)
+70 ;;=J2350^^48^580^80^^^^1
+71 ;;^UTILITY(U,$J,358.3,11921,1,0)
+72 ;;=^358.31IA^3^2
+73 ;;^UTILITY(U,$J,358.3,11921,1,2,0)
+74 ;;=2^J2350
+75 ;;^UTILITY(U,$J,358.3,11921,1,3,0)
+76 ;;=3^OCRELIZUMAB 1MG
+77 ;;^UTILITY(U,$J,358.3,11922,0)
+78 ;;=J3590^^48^580^105^^^^1
+79 ;;^UTILITY(U,$J,358.3,11922,1,0)
+80 ;;=^358.31IA^3^2
+81 ;;^UTILITY(U,$J,358.3,11922,1,2,0)
+82 ;;=2^J3590
+83 ;;^UTILITY(U,$J,358.3,11922,1,3,0)
+84 ;;=3^UNCLASSIFIED BIOLOGICS
+85 ;;^UTILITY(U,$J,358.3,11923,0)
+86 ;;=J3490^^48^580^106^^^^1
+87 ;;^UTILITY(U,$J,358.3,11923,1,0)
+88 ;;=^358.31IA^3^2
+89 ;;^UTILITY(U,$J,358.3,11923,1,2,0)
+90 ;;=2^J3490
+91 ;;^UTILITY(U,$J,358.3,11923,1,3,0)
+92 ;;=3^UNCLASSIFIED DRUG
+93 ;;^UTILITY(U,$J,358.3,11924,0)
+94 ;;=J0135^^48^580^3^^^^1
+95 ;;^UTILITY(U,$J,358.3,11924,1,0)
+96 ;;=^358.31IA^3^2
+97 ;;^UTILITY(U,$J,358.3,11924,1,2,0)
+98 ;;=2^J0135
+99 ;;^UTILITY(U,$J,358.3,11924,1,3,0)
+100 ;;=3^ADALIMUMAB 20MG
+101 ;;^UTILITY(U,$J,358.3,11925,0)
+102 ;;=J1569^^48^580^45^^^^1
+103 ;;^UTILITY(U,$J,358.3,11925,1,0)
+104 ;;=^358.31IA^3^2
+105 ;;^UTILITY(U,$J,358.3,11925,1,2,0)
+106 ;;=2^J1569
+107 ;;^UTILITY(U,$J,358.3,11925,1,3,0)
+108 ;;=3^GAMMAGARD LIQUID 500MG
+109 ;;^UTILITY(U,$J,358.3,11926,0)
+110 ;;=J1566^^48^580^51^^^^1
+111 ;;^UTILITY(U,$J,358.3,11926,1,0)
+112 ;;=^358.31IA^3^2
+113 ;;^UTILITY(U,$J,358.3,11926,1,2,0)
+114 ;;=2^J1566
+115 ;;^UTILITY(U,$J,358.3,11926,1,3,0)
+116 ;;=3^IMMUNE GLOBULIN 500MG
+117 ;;^UTILITY(U,$J,358.3,11927,0)
+118 ;;=J2182^^48^580^69^^^^1
+119 ;;^UTILITY(U,$J,358.3,11927,1,0)
+120 ;;=^358.31IA^3^2
